基于多模态数据的甲状腺髓样癌中央区淋巴结转移术前预测模型的构建与分析OA
Construction and analysis of a preoperative prediction model for central lymph node metastasis in medullary thyroid carcinoma based on multimodal data
目的:基于多模态数据构建甲状腺髓样癌(medullary thyroid carcinoma,MTC)中央区淋巴结转移(central lymph node metastasis,CLNM)的预测模型,并分析其临床意义.方法:回顾性分析2017年1月—2025年5月南京医科大学第一附属医院收治的104例MTC患者的临床病理资料、术前影像学特征及实验室指标.通过单因素Logistic回归初步筛选变量(P<0.1),进一步采用向后逐步回归法进行多因素Logistic回归分析筛选CLNM的独立危险因素,构建预测模型并绘制列线图,受试者工作特征(receiver operating characteristic,ROC)曲线、校准曲线和决策曲线分析(decision curve analysis,DCA)评估模型的区分度、校准度和临床适用性,使用Bootstrap法进行内部验证.结果:根据病理结果是否存在CLNM将104例MTC患者分成转移组(55例)与非转移组(49例).与非转移组患者相比,转移组患者性别(P=0.001)、超声形态是否规则(P<0.001)、超声边缘是否光整(P<0.001)、血清癌胚抗原(carcinoembryonic antigen,CEA)水平(P=0.006)、血清降钙素(calcitonin,CT)水平(P<0.001)等差异有统计学意义.多因素Logistic回归分析显示,患者的性别(OR=6.50,95%CI:2.03~20.81,P=0.002)、超声边缘是否光整(OR=9.77,95%CI:3.12~30.59,P<0.001)以及血清CT水平(OR=1.25,95%CI:1.10~1.42,P<0.001)是CLNM的独立危险因素.联合三者建立的列线图模型可良好地识别CLNM,ROC曲线下面积(area under the curve,AUC)为0.873,95%CI:0.808~0.939,校准曲线和DCA均表明该模型具有良好的性能及临床适用性.使用Bootstrap法进行内部验证也显示该模型具有良好的稳定性和可靠性(AUC=0.874,95%CI:0.865~0.879).结论:结合患者的性别、超声边缘是否光整以及血清CT水平的多模态数据模型能有效预测MTC患者CLNM风险,为临床决策提供依据.
Objective:To develop and validate a multimodal data-based predictive model for central lymph node metastasis(CLNM)in patients with medullary thyroid carcinoma(MTC)and evaluate its clinical significance.Methods:We retrospectively analyzed clinical-pathological data,preoperative imaging features,and laboratory parameters of 104 MTC patients treated at the First Affiliated Hospital of Nanjing Medical University between January 2017 and May 2025.Potential predictors(P<0.1 in univariate analysis)were included in a multivariate logistic regression model with backward stepwise selection to identify independent risk factors for CLNM.A prediction model was constructed and a nomogram was drawn.The receiver operating characteristic(ROC)curve,calibration curve and decision curve analysis(DCA)were used to evaluate the discrimination,calibration,and clinical applicability of the model.Internal validation was performed via bootstrap resampling.Results:According to the presence or absence of CLNM in the pathological results,104 MTC patients were classified into CLNM-positive(n=55)and CLNM-negative(n=49)groups.Compared to the CLNM-negative group,CLNM-positive patients showed significant differences in sex(P=0.001),whether the ultrasound(US)tumor morphology was regular(P<0.001),whether US tumor margin was smooth(P<0.001),serum carcinoembryonic antigen(CEA)level(P=0.006),and serum calcitonin(CT)level(P<0.001).Multivariate analysis identified male gender(OR=6.50,95%CI:2.03-20.81;P=0.002),non-circumscribed US margins(OR=9.77,95%CI:3.12-30.59,P<0.001),and elevated serumCT(OR=1.25,95%CI:1.10-1.42,P<0.001)as independent risk factors for CLNM.The nomogram integrating these factors demonstrated excellent discrimination(AUC=0.873,95%CI:0.808-0.939),with good calibration and clinical utility on DCA.Bootstrap validation confirmed model stability(AUC=0.874,95%CI:0.865-0.879).Conclusion:A multimodal model incorporating sex,US tumor margin status,and serum CT levels effectively predicts CLNM risk in MTC patients,providing a valuable tool for clinical decision-making.
ZHANG Xiang;LIU Wei;YANG Qianqian;ZHANG Yan
@@@1Department of Laboratory Medicine,2Department of Nuclear Medicine,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029||3Department of Laboratory Medicine,Nanjing Meishan Hospital,Nanjing 210039,China@@@1Department of Laboratory Medicine,2Department of Nuclear Medicine,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029||3Department of Laboratory Medicine,Nanjing Meishan Hospital,Nanjing 210039,China@@@1Department of Laboratory Medicine,2Department of Nuclear Medicine,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029||3Department of Laboratory Medicine,Nanjing Meishan Hospital,Nanjing 210039,China@@@1Department of Laboratory Medicine,2Department of Nuclear Medicine,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029||3Department of Laboratory Medicine,Nanjing Meishan Hospital,Nanjing 210039,China
医药卫生
甲状腺髓样癌中央区淋巴结转移多模态数据预测模型
medullary thyroid carcinomacentral lymph node metastasismultimodal dataprediction model
《南京医科大学学报(自然科学版)》 2026 (1)
14-20,7
江苏省医学重点学科(ZDXK202239)
评论